Harvard Bioscience Inc. logo

Harvard Bioscience Inc.

HBIO | NASDAQ
Chart Builder DCF Calculator
$8.09
+$0.14 (+1.76%)
Sep 21, 2026, 3:08 PM ET · Market open

Market Data

Market Cap
$35.86M
Enterprise Value
$73.56M
Beta
1.53
Average Volume
21.99K
Shares Outstanding (Diluted)
4.53M
Shares Change YoY
2.16%
Institutional Ownership
35.45%
Exchange
NASDAQ
ISIN
US4169062043

Price Performance

Price Change 1M
11.7%
Price Change 3M
31.2%
Price Change 6M
48.9%
Price Change YTD
21.9%
Price Change 1Y
64.6%
Price Change 3Y
-80.6%
Price Change 5Y
-89.7%
1M CAGR (ann.)
28.4%
1Y CAGR (ann.)
70.6%
5Y CAGR (ann.)
-36.5%
All-Time CAGR
-7.7%

Valuation

PE Ratio
-3.41
Forward PE
11.38
PEG Ratio
-0.05
Forward PEG
0.01
PS Ratio
0.41
Forward PS
0.40
PB Ratio
4.83
P/FCF Ratio
-25.43
P/Adj. FCF Ratio
-16.35
P/OCF Ratio
56.79
EV/Sales
0.84
EV/EBIT
-10.29
EV/EBITDA
-78.34
EV/FCF
-52.17
Earnings Yield
-29.3%
FCF Yield
-3.9%
Adj. FCF Yield
-6.1%

Financial Health

Net Debt
$30.18M
Total Debt
$44.21M
Cash & Short-Term Investments
$6.5M
Total Assets
$76.29M
Current Ratio
1.87
Quick Ratio
0.98
Debt / Equity Ratio
5.96
Debt / EBITDA
-47.08
Debt / FCF
-31.35
OCF / Debt
0.01
Interest Coverage
0.30
Altman Z-Score
-2.56
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
58.2%
Operating Profit Margin
1.2%
EBITDA Margin
-1.1%
Net Profit Margin
-11.9%
FCF Margin
-1.6%
Adj. FCF Margin
-2.5%
SBC / Revenue
1.2%
SBC Impact (per share)
-55.5%

Returns

Return on Assets
-13.7%
Return on Equity
-92.0%
Return on Invested Capital
1.9%
Return on Capital Employed
2.0%
Return on Tangible Assets
-17.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-8.4%
Revenue CAGR 5Y
-4.6%
Revenue CAGR 10Y
-2.0%
EPS CAGR 3Y
1.4%
EPS CAGR 5Y
-35.9%
EPS CAGR 10Y
-23.7%
FCF CAGR 3Y
-128.0%
FCF CAGR 5Y
12.7%
FCF CAGR 10Y
-4.8%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$38
Price Target Upside
378.0%

Cash Flow

Operating Cash Flow
$651K
Free Cash Flow
$-1.41M
Adj. Free Cash Flow
$-2.19M
FCF Per Share
-$0.31
OCF Per Share
$0.14
OCF/S Ratio
0.7%

Income Statement

Revenue
$87.81M
Gross Profit
$51.07M
Operating Income
$1.03M
EBITDA
$-939K
Net Income
$-10.41M
EPS (Diluted)
-$2.33
Revenue / Employee
$267.71K
Profit / Employee
$-31.74K
Employees
328

© 2026 bestshares.com. All rights reserved.